Intervention

Cataract surgery

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting2

Common conditions17

Lead sponsors shown8

Clinical trials

12 shown

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle GlaucomaNCT05564091 · 2022-09-08

Hydrus® Microstent New Enrollment Post-Approval StudyNCT04553523 · 2020-08-25

A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly PatientsNCT04074954 · 2023-03-23

Swedish Microinvasive Glaucoma Surgery Study (SMIGS)NCT05035394 · 2021-09-16

ACTIVE_NOT_RECRUITING

Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACSNCT04856670 · 2021-05-25

Diabetic Retinopathy and OCT-A Changes Post-cataract SurgeryNCT04660006 · 2019-05-27

Post Approval Study of the CyPass SystemNCT03273907 · 2017-10-12

Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract SurgeryNCT01841450 · 2013-07-01

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract SurgeryNCT01461291 · 2012-01-16

Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)NCT01539239 · 2012-01-01

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract SurgeryNCT01461278 · 2011-12-22

Autoimmune Dysregulation in Pigmentary GlaucomaNCT00280345 · 2006-02-01

Common conditions

Cataract6 Primary Open Angle Glaucoma5 Primary Open-angle Glaucoma3 Cystoid Macular Edema1 Diabetes1 Diabetes Mellitus1 Diabetic Retinopathy1 Goniotomy1 Hypertension1 Istent Inject W1 Kahook Dual Blade Glide1 Macular Edema Due to Diabetes Mellitus1 MIGS1 Obesity1 Open Angle Glaucoma1 Pigmentary Glaucoma1 Vision Disability1

Leading sponsors

Glaukos Corporation3 Alcon Research2 Uptown Eye Specialists2 Ivantis, Inc.1 Nova Eye, Inc.1 Umeå University1 University of Oklahoma1 University of Pikeville1

Trial status mix

COMPLETED4

UNKNOWN3

RECRUITING2

ACTIVE_NOT_RECRUITING1

TERMINATED1

WITHDRAWN1

Phase mix

NA9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.